+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Abundance of mRNA of apolipoprotein b100, apolipoprotein e, and microsomal triglyceride transfer protein in liver from periparturient dairy cows



Abundance of mRNA of apolipoprotein b100, apolipoprotein e, and microsomal triglyceride transfer protein in liver from periparturient dairy cows



Journal of Dairy Science 87(9): 2881-2888



Limited secretion of very low density lipoproteins (VLDL) in dairy cows is strongly related to fatty liver and other metabolic disorders in the early postpartum. Currently, there is limited information on which roles apolipoprotein B(100) (ApoB(100)), apolipoprotein E (ApoE), and microsomal triglyceride transfer protein (MTP) play in that VLDL limitation. To our knowledge, no studies have simultaneously measured ApoB(100), ApoE, and MTP mRNA in periparturient dairy cows. Therefore, a trial was conducted to assess liver gene expression of these proteins in transition dairy cows and to evaluate the relationships between their expression and metabolic status. Eight multiparous Holstein cows were monitored during the transition period. To evaluate metabolic and nutritional status, body condition score was registered, and plasma indexes of energy metabolism and VLDL were determined from 35 d before to 35 d after calving. Liver biopsies were performed on d -35, 3, and 35 relative to day of calving, and gene expression of ApoB(100), ApoE, and MTP were determined on liver tissue. Body condition, plasma glucose and VLDL decreased, and plasma NEFA and BHBA increased after calving. Compared with values of d -35, on d 3 after calving the ApoB(100) mRNA synthesis was lower, whereas MTP and ApoE mRNA abundance were higher. Negative correlation (r = -0.57) between plasma NEFA concentration and ApoB(100) mRNA abundance, and positive correlation between ApoB(100) mRNA abundance and plasma cholesterol (r = 0.65) and plasma albumins (r = 0.52) were detected at 3 d postpartum. Data on changes of gene expression of the 3 main proteins involved in the regulation of synthesis and secretion of VLDL in the liver suggest that decreased mRNA for ApoB(100) may be consistent with decreased synthesis and/or secretion of VLDL from liver during the periparturient period.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004026892

Download citation: RISBibTeXText

PMID: 15375048

DOI: 10.3168/jds.s0022-0302(04)73418-9


Related references

Effects of different energy intake in the dry period on abundance of apolipoprotein B100 mRNA in liver of periparturient dairy cows. Chinese Journal of Veterinary Science 26(3): 320-322, 325, 2006

Expression of apolipoprotein B100 mRNA in the liver of periparturient dairy cows with high energy intake. Journal of Jilin Agricultural University 27(5): 538-542, 2005

Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. Journal of Biological Chemistry 272(33): 20435-20442, 1997

The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis. Journal of Biological Chemistry 277(6): 4413-4421, 2002

Identification of domains in apolipoprotein B100 that confer a high requirement for the microsomal triglyceride transfer protein. Journal of Biological Chemistry 274(4): 1986-1993, 1999

Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells. PhytoTherapy Research 22(12): 1640-1645, 2008

Quantitative studies of microsomal triglyceride transfer protein and apolipoprotein B mRNA in human hearts reveal increased MTP and apoB gene expression in ischemic left ventricle and an association of MTP mRNA with triglyceride content. Circulation 102(18 Suppl.): II 147, 2000

Construction of template for detecting changes of microsomal triglyceride transfer protein mRNA in liver of dairy cows. Chinese Journal of Veterinary Science and Technology 35(9): 731-734, 2005

Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 54(6): 1676-1683, 2005

The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells. Journal of Biological Chemistry 271(24): 14124-14133, 1996

The microsomal triglyceride transfer protein mediates both translocation of apolipoprotein B into the endoplasmic reticulum and the addition of core lipid in the formation of apolipoprotein B-100 very low density lipoprotein. Circulation 92(8 Suppl. ): I362, 1995

Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells. Journal of Biological Chemistry 276(30): 28606-28612, 2001

Changes in hepatic microsomal triglyceride transfer protein and triglyceride in periparturient dairy cattle. Journal of Dairy Science 83(10): 2252-2260, 2000

Abnormal histopathology, fat percent and hepatic apolipoprotein A I and apolipoprotein B100 mRNA expression in fatty liver hemorrhagic syndrome and their improvement by soybean lecithin. Poultry Science 96(10): 3559-3563, 2017

Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction. Molecular Pharmacology 61(2): 269-276, 2002